takisbiotech
Menu
Close
Company
About Us
Our Team
Careers
Our Services
Vaccines & Preclinical Immunology
Predictive Models
Monoclonal Antibodies
Recombinant Proteins
Facilities
BSL-3
GMP
Research
Funded Projects
Internal Research
Papers
Congresses
News
Contact Us
Company
About Us
Our Team
Careers
Our Services
Vaccines & Preclinical Immunology
Predictive Models
Monoclonal Antibodies
Recombinant Proteins
Facilities
BSL-3
GMP
Research
Funded Projects
Internal Research
Papers
Congresses
News
Contact Us
Company news
Stay updated with Takis latest news!
Science needs to run fast, so do we!
September 24, 2024
|
News
|
What’s better than an “aperitivo” on the beach to celebrate the start of the summer holidays?
August 2, 2024
|
News
|
Takis at the RomeTechnopole Spoke 6 – International Young Researcher Workshop!
July 11, 2024
|
News
|
On July 8th, Federica Signoretti and Matthew Golden from the U.S. Embassy came to Takis to learn about our company, our history, and the programs we are developing.
July 11, 2024
|
News
|
Takis at EACR2024: Innovation in Cancer Therapy
June 19, 2024
|
News
|
Takis participated at the Flagship Project 7 Mid-term plenary workshop!
June 14, 2024
|
News
|
We are thrilled to announce that Takis has been selected among 13 European companies for the IPCEI “Med4Cure” project, the first Important Project of Common European Interest in the Health value chain.
May 30, 2024
|
News
|
Biotechnologies are emerging as key strategies for citizens’ health and for countries economy
May 17, 2024
|
News
|
CEO, Luigi Aurisicchio, recently joined the event Italy and Latin America
May 9, 2024
|
News
|
1
2
3
4
